21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118674/0/en/Disc-Medicine-Announces-Positive-Pre-NDA-Meeting-and-Confirms-Plans-to-Submit-NDA-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP-in-October-2025.html
01 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/01/2973535/0/en/Disc-Medicine-to-Host-Conference-Call-on-End-of-Phase-2-FDA-Meeting-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP.html
08 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/08/2926880/0/en/Disc-Medicine-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
01 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/01/2855150/0/en/Disc-Reports-Topline-Results-from-Phase-2-AURORA-Study-of-Bitopertin-in-Patients-with-Erythropoietic-Protoporphyria-EPP.html
11 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/12/2794346/0/en/Disc-Presents-Positive-Updated-Results-from-Phase-2-BEACON-Study-of-Bitopertin-and-Other-Programs-at-the-65th-American-Society-of-Hematology-ASH-Annual-Meeting.html
27 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/27/2712248/0/en/Disc-Medicine-Announces-First-Patient-Enrolled-in-Phase-1-2-Clinical-Trial-of-Bitopertin-in-Diamond-Blackfan-Anemia-DBA.html